| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.32 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |